Advertisement
Canada markets closed

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7319
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    83.42
    +0.06 (+0.07%)
     

  • Bitcoin CAD

    91,044.75
    +108.18 (+0.12%)
     

  • CMC Crypto 200

    1,434.91
    +20.15 (+1.42%)
     

  • GOLD FUTURES

    2,338.10
    -4.00 (-0.17%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,737.25
    +130.50 (+0.74%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    38,326.29
    +774.13 (+2.06%)
     

  • CAD/EUR

    0.6834
    -0.0002 (-0.03%)
     

Why Shares of Accuray Rose Thursday

Jim Halley, The Motley Fool
·2 min read
Why Shares of Accuray Rose Thursday

Shares of Accuray (NASDAQ: ARAY) were up by more than 15% early Thursday afternoon after the healthcare company released its fiscal 2023 third-quarter earnings Wednesday afternoon. The radiation oncology device specialist makes the CyberKnife and Tomo Therapy systems, which deliver radiosurgery, stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The fiscal quarter, which ended March 31, was the company's first in the black since its fiscal 2022 second quarter (i.e., calendar Q4 2021).

Continue reading